Invention Grant
- Patent Title: Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof
- Patent Title (中): 厄洛替尼或其药学上可接受的盐的制备方法
-
Application No.: US13258961Application Date: 2010-03-26
-
Publication No.: US08440823B2Publication Date: 2013-05-14
- Inventor: Balaguru Murugesan , Anandam Vempali , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
- Applicant: Balaguru Murugesan , Anandam Vempali , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
- Applicant Address: IN New Delhi
- Assignee: Ranbaxy Laboratories Limited
- Current Assignee: Ranbaxy Laboratories Limited
- Current Assignee Address: IN New Delhi
- Priority: IN596/DEL/2009 20090326; IN483/DEL/2010 20100304
- International Application: PCT/IB2010/051343 WO 20100326
- International Announcement: WO2010/109443 WO 20100930
- Main IPC: C07D401/00
- IPC: C07D401/00
Abstract:
The present invention relates to a process for preparation of erlotinib of Formula I or its pharmaceutically acceptable salt thereof. The present invention also relates to process for the preparation of erlotinib trifluoroacetate. The present invention also relates to a nove-ICrystalline form of erlotinib trifluoroacetate designated as Form E and process for its preparation. The present invention further relates to process for the preparation of erlotinib hydrochloride from erlotinib trifluoroacetate.
Public/Granted literature
- US20120101272A1 PROCESS FOR THE PREPARATION OF ERLOTINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF Public/Granted day:2012-04-26
Information query
